[go: up one dir, main page]

PE20071225A1 - Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina - Google Patents

Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina

Info

Publication number
PE20071225A1
PE20071225A1 PE2007000467A PE2007000467A PE20071225A1 PE 20071225 A1 PE20071225 A1 PE 20071225A1 PE 2007000467 A PE2007000467 A PE 2007000467A PE 2007000467 A PE2007000467 A PE 2007000467A PE 20071225 A1 PE20071225 A1 PE 20071225A1
Authority
PE
Peru
Prior art keywords
alkyl
phenyl
methyl
neurocinin
piperidine
Prior art date
Application number
PE2007000467A
Other languages
English (en)
Inventor
Andrew P Degnan
George Tora
Ying Han
Ramkumar Rajamani
Derek J Denhart
Jonathan L Ditta
Kevin W Gillman
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20071225A1 publication Critical patent/PE20071225A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIPERIDINA DE FORMULA (I) DONDE R1 ES H, ALQUILO(C1-C6), CICLOALQUILO(C3-C7) O BENCILO; R2 ES H O ALQUILO(C1-C6); R3 ES H O ALQUILO(C1-C6); R4 ES H, ALQUILO(C1-C6), HALOALQUILO(C1-C6), CN, ENTRE OTROS; R5 ES H, ALQUILO(C1-C6), HALOALQUILO(C1-C6), HIDROXI, ENTRE OTROS; Ar1 ES FENILO O PIRIDINILO SUSTITUIDO CON HALO, ALQUILO(C1-C6), HALOALQUILO(C1-C6), CN, FENILO O FURANILO; Ar2 ES FENILO, NAFTILO, FURANILO, ENTRE OTROS, SUSTITUIDOS CON HALO, ALQUILO(C1-C6), CN, NITRO, ENTRE OTROS SUSTITUYENTES. SON COMPUESTOS PREFERIDOS: 2-METOXI-5-(3-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-5-(TRIFLUOROMETIL)FENIL)PIRIMIDINA, 4-(5-(3-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-5-(TRIFLUOROMETIL)FENIL)PIRIDIN-2-IL)MORFOLINA, 3-METIL-4-(3-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-5-(TRIFLUOROMETIL)FENIL)PIRIDINA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE NEUROCININA-1 (NK-1) Y DEL TRANSPORTADOR DE SEROTONINA SIENDO UTILES EN EL TRATAMIENTO DE ESQUIZOFRENIA, DEMENCIA, ASMA, RINITIS
PE2007000467A 2006-04-17 2007-04-17 Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina PE20071225A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79260406P 2006-04-17 2006-04-17
US11/734,809 US20070249607A1 (en) 2006-04-17 2007-04-13 Nk-1 and serotonin transporter inhibitors

Publications (1)

Publication Number Publication Date
PE20071225A1 true PE20071225A1 (es) 2008-01-14

Family

ID=38510473

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000467A PE20071225A1 (es) 2006-04-17 2007-04-17 Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina

Country Status (5)

Country Link
US (2) US20070249607A1 (es)
AR (1) AR060496A1 (es)
PE (1) PE20071225A1 (es)
TW (1) TW200811135A (es)
WO (1) WO2007121389A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008014247A2 (en) * 2006-07-27 2008-01-31 Bristol-Myers Squibb Company 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders
US8071778B2 (en) * 2006-07-27 2011-12-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
JP4827986B2 (ja) 2007-06-08 2011-11-30 マンカインド コーポレ−ション ＩＲＥ−１αインヒビター
US8026257B2 (en) * 2007-07-11 2011-09-27 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
US20090018163A1 (en) * 2007-07-11 2009-01-15 Bristol-Myers Squibb Company Substituted Heterocyclic Ethers and Their Use in CNS Disorders
US7632861B2 (en) * 2007-11-13 2009-12-15 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
WO2009096941A1 (en) * 2008-01-28 2009-08-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in cns disorders
ES2401224T3 (es) * 2008-11-14 2013-04-17 Theravance, Inc. Procedimiento para la preparación de compuestos de 4-[2-(2-fluorofenoximetil)fenil]piperidina
WO2018169818A1 (en) * 2017-03-12 2018-09-20 Xiaodong Wang Polycyclic amines as opioid receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337418C (en) 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
WO1994010165A1 (en) * 1992-10-28 1994-05-11 Merck Sharp & Dohme Limited 4-arylmethyloxymethyl piperidines as tachykinin antagonists
DE69504300T2 (de) * 1994-01-13 1999-04-29 Merck Sharp & Dohme Ltd., Hoddesdon, Hertfordshire Gem-bissubstituierte azazyclische tachykinin-antagonisten
ATE469875T1 (de) 2002-03-13 2010-06-15 Schering Corp Nk1-antagonisten
US7041682B2 (en) * 2002-07-03 2006-05-09 Schering Corporation NK1 antagonists
AU2003258937A1 (en) 2002-09-09 2004-03-29 Astrazeneca Ab Naphthyl ether compounds and their use
US7098203B2 (en) * 2004-07-20 2006-08-29 Bristol-Myers Squibb Company Homopiperidine derivatives as NK-1 antagonists
US7138423B2 (en) * 2004-07-20 2006-11-21 Bristol-Myers Squibb Company Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
US7494986B2 (en) * 2004-07-20 2009-02-24 Bristol-Myers Squibb Company Cycloalkylamine derivatives as NK-1/SSRI antagonists
US7276631B2 (en) * 2004-07-20 2007-10-02 Bristol-Myers Squibb Company Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists

Also Published As

Publication number Publication date
US20070249607A1 (en) 2007-10-25
US8383821B2 (en) 2013-02-26
WO2007121389A2 (en) 2007-10-25
TW200811135A (en) 2008-03-01
AR060496A1 (es) 2008-06-18
US20100087434A1 (en) 2010-04-08
WO2007121389A3 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
PE20071225A1 (es) Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina
PE20191757A1 (es) Compuestos heterociclicos utiles como inhibidores dobles de atx/ca
PE20141681A1 (es) Inhibidores de btk
PE20090717A1 (es) Derivados de quinolina como inhibidores de la pi3 quinasa
PE20081836A1 (es) Derivados de piperidina como inhibidores de la sintasa de acido graso
NZ588652A (en) Carboxamide compounds for the treatment of metabolic disorders
EA201000561A1 (ru) Производные пиридина, пригодные в качестве активаторов глюкокиназы
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
PE20141375A1 (es) Activadores de glucoquinasa
PE20090288A1 (es) Derivados de quinoxalina como inhibidores de la pi3 quinasa
AR059249A1 (es) Compuesto amina trisustituido
PE20091653A1 (es) Derivados sustituidos de pirazol y su uso
PE20090949A1 (es) Compuesto heterociclico y composicion farmaceutica del mismo
PE20142099A1 (es) Derivados de sulfonamida
PE20090974A1 (es) Mezclas fungicidas
PE20141120A1 (es) Compuestos heterociclicos
PE20091656A1 (es) Compuestos heterociclicos como inhibidores de la cinasa raf
PE20120321A1 (es) Indazoles sustituidos con oxazol como inhibidores de pi3-quinasa
PE20120690A1 (es) Derivados de 5-fluoropirimidinona
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20130774A1 (es) Compuestos heterociclicos activadores de ampk y metodos para emplearlos
PE20140207A1 (es) Composiciones y metodos para modular el fxr
PE20090773A1 (es) Derivados de morfolina pirimidina
PE20110875A1 (es) Derivados de isoindol como inhibidores de bace

Legal Events

Date Code Title Description
FC Refusal